Hypothyroidism and Sleep: Why Rest Doesn't Restore — and What Helps

Hypothyroidism disrupts sleep in both directions — daytime sleepiness pre-treatment, sometimes insomnia from over-replacement. Obstructive sleep apnea is over-represented in untreated hypothyroidism and rarely resolves on levothyroxine alone. If you snore loudly or feel sleepy despite a normal TSH, ask for a sleep study.

How hypothyroidism affects sleep

Thyroid hormone sets the metabolic tempo of nearly every tissue, including the brain regions that regulate wakefulness, sleep architecture, and respiratory drive. When levels fall, several things happen at once [C1][C2][C6]:

• Daytime sleepiness and hypersomnia. Patients sleep longer, nap more, and still wake unrefreshed. This is the classic presentation of overt hypothyroidism.
• Altered sleep architecture. Sleep studies show reduced slow-wave (deep) sleep and fragmented sleep continuity in untreated patients, which is why hours-in-bed don't translate to feeling rested [C2][C3].
• Reduced respiratory drive. Lower metabolic rate, blunted ventilatory response to CO₂, and reduced upper-airway muscle tone all push patients toward sleep-disordered breathing [C3][C4].
• Tissue changes in the airway. Untreated hypothyroidism deposits mucopolysaccharide-rich tissue (myxedema) in the tongue, pharynx, and soft palate — narrowing the airway and raising apnea risk [C3][C5].

The end result is a sleep problem that masquerades as "just being tired." Many patients are diagnosed with hypothyroidism only after a sleep study or a partner notices loud snoring and pauses in breathing [C3].

Why obstructive sleep apnea is so common

Obstructive sleep apnea (OSA) is meaningfully over-represented in hypothyroid patients compared with the general population. Recent reviews report prevalence estimates ranging widely depending on severity of hypothyroidism studied, but most series cluster well above the background rate [C3]. Several mechanisms converge [C3][C4][C5]:

1. Macroglossia and pharyngeal tissue thickening. Mucopolysaccharide deposition enlarges the tongue and narrows the airway in untreated hypothyroidism [C5].
2. Weight gain. Hypothyroidism is associated with modest weight gain, and excess weight is the single strongest modifiable risk factor for OSA [C3][C4].
3. Reduced upper-airway muscle tone. Lower thyroid hormone reduces the activity of genioglossus and other dilator muscles that keep the airway patent during sleep [C3].
4. Blunted ventilatory response. Hypothyroid patients have a reduced respiratory drive in response to rising CO₂, which prolongs apneic episodes [C3][C4].

The 2025 OSA guidelines explicitly list hypothyroidism among the endocrine conditions worth screening for in patients with OSA, and the relationship is bidirectional — untreated OSA is also associated with thyroid dysfunction [C4].

What gets better on levothyroxine

Restoring a normal TSH on levothyroxine improves several sleep-related symptoms — but not all of them [C1][C2][C6]:

• Daytime sleepiness usually improves within weeks of reaching the target TSH range. This is one of the earlier-resolving hypothyroid symptoms.
• Sleep architecture partially recovers. Slow-wave sleep increases as metabolic function normalizes [C2].
• OSA does not reliably resolve on levothyroxine alone. Some patients see a modest reduction in apnea-hypopnea index (AHI) after thyroid replacement, but most still meet diagnostic criteria for OSA and need CPAP, weight management, or surgical evaluation [C3][C4].
• Tongue/airway tissue changes regress slowly if at all. Once anatomic remodeling has occurred, it doesn't fully reverse with thyroid treatment [C5].

The practical takeaway: levothyroxine fixes the metabolic and sleepiness components, but OSA needs its own diagnosis and its own treatment [C3][C4].

When sleep stays bad despite normal TSH

If your TSH is in target range and sleep is still broken, the diagnosis usually isn't "thyroid." Common culprits [C1][C3][C4][C7]:

1. Undiagnosed obstructive sleep apnea. The single most under-recognized cause of persistent fatigue in hypothyroid patients [C3][C4].
2. Over-replacement insomnia. Suppressed TSH (below 0.1 mIU/L) acts like subclinical hyperthyroidism — racing heart, anxiety, and difficulty falling or staying asleep. Resolves with dose reduction [C1][C7].
3. Iron deficiency and restless legs. Low ferritin (below ~50 ng/mL) commonly drives restless legs syndrome and fragmented sleep, and is over-represented in hypothyroid patients.
4. Comorbid depression or anxiety. Both are over-represented in hypothyroidism and Hashimoto's and have their own effects on sleep architecture [C2][C7].
5. Sleep hygiene. Late caffeine, irregular schedules, screen exposure, and alcohol disrupt sleep regardless of thyroid status.
6. Medication timing. Some patients on bedtime levothyroxine report sleep disturbance; switching to morning dosing can help. See our bedtime-levothyroxine-dosing article.

When to ask for a sleep study

Screen yourself with the well-validated questions used in the 2025 OSA guidelines [C4]. Ask for a sleep study (polysomnography or a validated home sleep apnea test) if you have one or more of [C3][C4]:

• Loud snoring plus daytime sleepiness — the classic two-symptom combination
• Witnessed apneas or gasping during sleep (usually reported by a partner)
• Resistant hypertension — blood pressure that won't normalize on multiple medications
• High STOP-BANG score (≥3 of: Snoring, Tiredness, Observed apneas, Pressure, BMI >35, Age >50, Neck circumference >40 cm, Male sex)
• Persistent daytime sleepiness despite TSH in target range

A sleep study is the only way to diagnose OSA — TSH and physical exam cannot replace it [C4].

What does NOT help

Several heavily-marketed sleep interventions have either no evidence or active risk in the hypothyroid population [C1][C6][C7]:

• Melatonin mega-doses. Doses of 5–10 mg are far above the physiologic range. Evidence for sleep onset benefit is modest; doses this high can cause morning grogginess and have unclear effects on thyroid hormone signaling.
• Ashwagandha "for sleep." Marketed as a thyroid and sleep "adaptogen," but documented to push some patients into thyrotoxicosis and to destabilize Hashimoto's. Not a sleep aid for thyroid patients. See our ashwagandha-thyroid article.
• CBD as a primary fix. Limited and inconsistent evidence for sleep; can affect cytochrome P450 drug metabolism, including levothyroxine handling in the gut.
• Tinkering with levothyroxine dose to "sleep better." Raising the dose to push TSH lower causes insomnia, not better sleep. Lowering it to "calm down" causes worse fatigue [C1][C7].
• "Thyroid sleep" multivitamin blends. Usually contain iodine, kelp, and ashwagandha — all of which can destabilize Hashimoto's.

Practical guidelines

1. Confirm TSH is in target range (often 0.5–2.5 mIU/L for symptomatic patients) [C1].
2. Screen for OSA actively. Loud snoring, witnessed apneas, or unrefreshing sleep at any TSH warrants a sleep study referral [C3][C4].
3. Check ferritin if you have restless legs or trouble staying asleep. Aim for ferritin ≥50 ng/mL.
4. Practice basic sleep hygiene. Consistent schedule, dark cool room, no caffeine after early afternoon, no alcohol within 3 hours of bed.
5. If you're on bedtime levothyroxine and sleep poorly, try morning dosing for 6–8 weeks and compare [C1].
6. Don't self-adjust your levothyroxine dose to chase sleep — it backfires both directions [C1][C7].

Frequently asked questions

Will my insomnia go away on levothyroxine? If sleepiness and hypersomnia are the problem, yes — usually within weeks of reaching a normal TSH [C1][C6]. If you've developed insomnia on levothyroxine, the dose may be too high; a TSH check and possible dose reduction are the right next step [C1][C7].

Can hypothyroidism cause sleep apnea? Untreated hypothyroidism is a recognized risk factor for obstructive sleep apnea through tongue/airway tissue changes, weight gain, and reduced respiratory drive [C3][C4][C5]. The 2025 OSA guidelines list hypothyroidism among the endocrine conditions worth screening for in OSA patients [C4].

Will my sleep apnea go away if I treat my thyroid? Usually not entirely. Levothyroxine can modestly reduce apnea severity but most patients still meet diagnostic criteria and need CPAP, weight management, or surgical evaluation [C3][C4]. Treat both conditions in parallel.

Should I take melatonin if I have Hashimoto's? There's no specific contraindication, but the evidence for sleep benefit is modest at typical doses and the mega-doses sold over the counter (5–10 mg) are well above the physiologic range. If insomnia persists, look for over-replacement, sleep apnea, or iron deficiency first.

Is loud snoring on its own enough reason to get a sleep study? Loud snoring plus any one of: daytime sleepiness, witnessed apneas, resistant hypertension, or high STOP-BANG score — yes, ask for one [C4]. Snoring alone in an otherwise well person can be discussed with your primary care provider.

Bottom line

Hypothyroidism disrupts sleep in both directions — daytime sleepiness and non-restorative sleep when undertreated, insomnia when over-replaced [C1][C7]. Obstructive sleep apnea is meaningfully over-represented in untreated hypothyroidism through tongue/airway changes, weight gain, and reduced respiratory drive [C3][C4][C5]. Daytime sleepiness usually improves on levothyroxine within weeks of a normal TSH, but OSA rarely resolves on thyroid replacement alone and needs its own diagnosis [C3][C4]. If you snore loudly, wake unrefreshed, or feel sleepy despite a normal TSH, ask for a sleep study — not a higher dose [C1][C4].

Sources

1. [C1] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
2. [C2] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. PubMed: 12826640
3. [C3] Zhai L et al. Recent advances in the study of the correlation between obstructive sleep apnea and thyroid-disorders. 2025. PubMed: 40323542
4. [C4] Chinese Thoracic Society. Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025). 2026. PubMed: 41820035
5. [C5] Emfietzoglou R et al. Macroglossia in endocrine and metabolic disorders: current evidence, perspectives and challenges. 2024. PubMed: 39081187
6. [C6] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org
7. [C7] Baskaran BS et al. Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review. 2026. PubMed: 41559017

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.